Pharmacokinetics in pulmonary epithelial lining fluid and plasma of ampicillin and pivampicillin administered to horses

被引:5
|
作者
Winther, Lotte [1 ]
Baptiste, Keith Edward [1 ]
Friis, Christian [2 ]
机构
[1] Univ Copenhagen, Fac Life Sci, Dept Large Anim Sci, DK-2630 Taastrup, Denmark
[2] Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, DK-1870 Frederiksberg C, Denmark
关键词
Pulmonary epithelial lining fluid; Ampicillin; Pivampicillin; Bioavailability; Equine; RESPIRATORY-TRACT; ANTIMICROBIAL AGENTS; SODIUM AMPICILLIN; TISSUE CHAMBERS; AMOXICILLIN; BIOAVAILABILITY; SUSCEPTIBILITY; INFLAMMATION; FOALS; PENICILLINS;
D O I
10.1016/j.rvsc.2010.11.001
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Ampicillin concentrations in pulmonary epithelial lining fluid (PELF) and plasma was studied after single intravenous ampicillin administration (15 mg/kg) or single intragastric administration of its prodrug, pivampicillin (19.9 mg/kg) to horses and discussed in relation to minimum inhibitory concentrations (MIC) of common equine respiratory pathogens. After intravenous administration, elimination of ampicillin was fast and not detectable in plasma after 12 h in three out of six horses. Pivampicillin was absorbed well in non-fasted horses with an oral bioavailability of 36%. The degree of penetration of ampicillin into PELF, as described by the AUC(PELF)/AUC(plasma) ratio from 0 to 12 h was 0.40 after intravenous administration and 1.00 after pivampicillin administration. In horses, ampicillin administered either intravenously or orally, in the form of pivampicillin, can provide clinically relevant drug concentrations in PELF for at least 12 h, when treating susceptible equine respiratory pathogens (e.g. streptococci). Treatment of other bacterial pathogens requires susceptibility testing and possibly more frequent dosing, depending of minimum inhibitory concentrations (MIC) values. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:111 / 115
页数:5
相关论文
共 50 条
  • [31] Assessment of Epithelial Lining Fluid Partitioning of Systemically Administered Monoclonal Antibodies in Rats
    Boger, E.
    Erngren, T.
    Fihn, B. -M.
    Leonard, E.
    Rubin, K.
    Backstrom, E.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 112 (04) : 1130 - 1136
  • [32] Airway Epithelial Lining Fluid and Plasma Pharmacokinetics of Inhaled Fluticasone Propionate and Salmeterol Xinafoate in Mechanically Ventilated Pigs
    Ewing, Par
    Oag, Steven
    Lundqvist, Anders
    Stomilovic, Stina
    Stellert, Ida
    Antonsson, Malin
    Nunes, Sandro Filipe
    Andersson, Patrik U.
    Tehler, Ulrika
    Sjoberg, Carl
    Peterffy, AnnaMaria
    Gerde, Per
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2021, 34 (04) : 231 - 241
  • [33] PHARMACOKINETICS AND DISTRIBUTION OF AMPICILLIN IN PLASMA, MILK AND UTERINE FLUID OF FEMALE BUFFALOS
    JAYACHANDRAN, C
    SINGH, MK
    BANERJEE, NC
    VETERINARY RESEARCH COMMUNICATIONS, 1990, 14 (01) : 47 - 51
  • [34] Zanamivir Pharmacokinetics and Pulmonary Penetration into Epithelial Lining Fluid following Intravenous or Oral Inhaled Administration to Healthy Adult Subjects
    Shelton, Mark J.
    Lovern, Mark
    Ng-Cashin, Judith
    Jones, Lori
    Gould, Elizabeth
    Gauvin, Jennifer
    Rodvold, Keith A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (11) : 5178 - 5184
  • [35] OZONE-REACTIVE ABSORPTION BY PULMONARY EPITHELIAL LINING FLUID CONSTITUENTS
    LANGFORD, SD
    BIDANI, A
    POSTLETHWAIT, EM
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 132 (01) : 122 - 130
  • [36] INTERFACIAL TRANSFER KINETICS OF NO2 INTO PULMONARY EPITHELIAL LINING FLUID
    POSTLETHWAIT, EM
    LANGFORD, SD
    BIDANI, A
    JOURNAL OF APPLIED PHYSIOLOGY, 1991, 71 (04) : 1502 - 1510
  • [37] GLUTATHIONE DEFICIENCY IN THE EPITHELIAL LINING FLUID OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    CANTIN, A
    NORTH, L
    HUBBARD, R
    CRYSTAL, RG
    CLINICAL RESEARCH, 1985, 33 (02): : A270 - A270
  • [38] Comment on: "Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update"
    De Sutter, Pieter-Jan
    De Waele, Jan
    Vermeulen, An
    CLINICAL PHARMACOKINETICS, 2022, 61 (02) : 335 - 336
  • [39] REACTIVE ABSORPTION OF NITROGEN-DIOXIDE BY PULMONARY EPITHELIAL LINING FLUID
    POSTLETHWAIT, EM
    LANGFORD, SD
    BIDANI, A
    JOURNAL OF APPLIED PHYSIOLOGY, 1990, 69 (02) : 523 - 531
  • [40] Comment on: “Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update”
    Pieter-Jan De Sutter
    Jan De Waele
    An Vermeulen
    Clinical Pharmacokinetics, 2022, 61 : 335 - 336